According to a report by Newsmax on December 19th, American e-cigarette brand JUUL Labs has announced its intention to seek authorization from the US FDA to release a new mint-flavored pod that requires age verification for users.
In June 2022, JUUL's e-cigarette was temporarily banned in the United States after the Food and Drug Administration (FDA) determined that JUUL Labs failed to demonstrate the suitability of its product sales for public health. However, following JUUL Labs' appeal, the FDA suspended the ban and agreed to conduct additional scrutiny of JUUL's marketing application.
The newly introduced mint-flavored pod from the company contains a nicotine concentration of 18mg/ml. This is part of JUUL Labs' latest Pre-Market Tobacco Product Application (PMTA) submitted to the FDA.
JUUL Labs, a prominent e-cigarette company, has recently filed an application in the United States with the aim of introducing a new e-cigarette equipped with a distinctive pod. The purpose behind this innovative pod design is two-fold: to enhance anti-counterfeiting measures and to restrict usage among minors. The e-cigarette, known as the JUUL2 system, was successfully launched in the British market earlier this year in 2021.
The new mint-flavored e-cigarette pod comes with a safety microchip that requires age verification before use. The device can be locked by users at any time to prevent unauthorized usage. In order to minimize risks from underage access, JUUL Labs has announced that they will restrict the number of mint-flavored pods that can be purchased, activated, and used by each age-verified user.
However, up until now, the FDA has only authorized the sale of 23 e-cigarette products in the United States, and all of them are tobacco-flavored. The FDA has rejected applications for mint-flavored e-cigarettes from several well-known manufacturers, including British American Tobacco, and these companies are currently appealing these decisions.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
